University of California San Francisco

News & Events

Displaying 33 - 48 of 51

Johannes Kratz Named Van Auken Endowed Chair in Thoracic Oncology

UCSF Department of Surgery
February 24, 2018
Johannes R. Kratz, M.D. has been named the new Van Auken Endowed Chair in Thoracic Oncology. Kratz is an assistant professor in the Division of Adult Cardiothoracic Surgery, a member of the Thoracic Oncology Program, and director of Advanced Minimally Invasive Thoracic Surgery. The Van Auken Endowed Chair supports...
OR Vas 1097 Copy 300X188 Right Bar

UCSF Earns Highest Performance Rating for Procedures Performed by Cardiac, Colorectal, Thoracic, Vascular and Lung Transplant Surgeons

UCSF Department of Surgery
December 29, 2017
UCSF Medical Center earned “high performance” ratings – the highest ratings possible – in eight common conditions and procedures in the U.S. News & World Report Best Hospitals Survey for 2017-2018, seven within the UCSF Department of Surgery: Abdominal Aortic Aneurysm Repair Aortic Valve Surgery Colon Cancer...

Johannes Kratz Joins Department Faculty and Thoracic Oncology Program

UCSF Department of Surgery
July 01, 2017
The Department of Surgery welcomes Johannes R. Kratz, M.D. to the faculty as Assistant Professor in the Division of Adult Cardiothoracic Surgery and member of the Thoracic Oncology Program. Dr. Kratz was a surgical research fellow in the UCSF Thoracic Oncology Laboratory from 2008-2011 where he played a key role...

Thierry Jahan, M.D. Discusses Clinical Trial Using CRS-207 Vaccine in Mesothelioma

UCSF Thoracic Oncology Program
July 28, 2016
Former professor Thierry Jahan, M.D ., discussed clinical data from the study, Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma , at the ESMO/IASLC European Congress on Lung Cancer in Geneva in April 2016. This is a Phase Ib trial of CRS...

Study Suggests Prognostic Molecular Assay More Accurate than Conventional NCCN Criteria in Stratifying Risk in Early-Stage NSCLC Patients

UCSF Thoracic Oncology Program
November 07, 2014
Building on earlier retrospective validation studies , a team of Thoracic Oncology Program researchers, demonstrated in a small prospective study the clinical utility of a 14-gene expression assay in stratifying risk among non-small cell lung cancer (NSCLC) patients. In a recently published paper in the journal...
Rowan Jimenez - Rock Climber Cropped

Rock Climber Exceeds Expectations After Double-Lung Transplant at UCSF

UCSF Adult Cardiothoracic Surgery
November 08, 2012
UCSF News reports on the story of Rowan Jimenez, a rock climber who underwent a double lung transplant at UCSF for treatment of scleroderma, an autoimmune disease, crediting UCSF with getting his life back and resuming his passion for climbing mountains. The 10,911-foot view from the top of Cathedral Peak in...

NIH Awards $2.2m Collaborative Grant to Two UCSF Scientists

UCSF Thoracic Oncology Program
August 27, 2012
The NIH has awarded two UCF scientists, Hassan Lemjabbar-Alaoui, Ph.D and Joanna J. Phillips, M.D., Ph.D., a five-year $2.2m grant to study the clinical utility of extracellular heparan sulfate endosulfatases, or SULFs, as biomarkers for early detection of non-small cell lung cancer (NSCLC) and malignant...

UCSF-Pfizer Collaboration Project to Fast-Track Treatments for Lung Cancer

UCSF Thoracic Oncology Program
January 09, 2012
A team consisting of Hassan Lemjabbar-Alaoui, Ph.D., Assistant Adjunct Professor of Surgery and principal Investigator in the Thoracic Oncology Laboratory and Alaoui Lab, and Steven Rosen, PhD, Professor and Vice-chair of the Department of Anatomy, are developing a novel treatment for lung cancer in a unique...

Thierry Jahan Honored with Exceptional Physician Award

UCSF Thoracic Oncology Program
April 21, 2010
Thierry Jahan, M.D., an Associate Professor of Medicine Bonnie J. and Anthony Addario Endowed Chair in Thoracic Oncology, is one of four recipients of the 2010 UCSF Medical Center Exceptional Physician Award, an honor recognizing dedication to outstanding patient care and to the instiutions' values of...

Opera Star Sings Praises of Targeted Lung Cancer Therapy

UCSF Thoracic Oncology Program
July 20, 2009
Last October, opera singer Zheng Cao fell during a performance and had no idea why. Later, it turned out she had advanced lung cancer. Now, as a result of treatment with a new type of targeted therapy, her cancer is retreating. Personalized medicine - that is, customizing the treatment to the patient's tumor -is...